跳至主要内容
临床试验/TCTR20200420004
TCTR20200420004已完成不适用

Current era survival of treat and repair congenital systemic to pulmonary shunt with borderline pulmonary vascular disease

Faculty of Medicine0 个研究点目标入组 432 人开始时间: 2020年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
432

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
3 Months 至 80 Years(—)
性别
All

入选标准

  • 1.Patients who underwent cardiac catheterization to assess hemodynamic data or transcatheter closure of the defects in Siriraj Hospital between January 1st, 1995 and December 31st, 2021
  • 2.All patients who had evidence of PAH-CHD on the cardiac catheterization including mPAP >20 mmHg, PAWP < 15 mmHg and calculated PVR > 3 WU based on a current definition of PAH
  • 3.Patients who were classified in Eisenmenger syndrome and PAH-CHD with prevalent left to right shunt

排除标准

  • 1.Patients who had age < 3 months,
  • 2.Patients with single ventricle following surgery
  • 3.Patients who were classified in PAH with small defect and PAH following defect correction

研究者

发起方
Faculty of Medicine

相似试验